|
|
Line 14: |
Line 14: |
| * In case of high suspicion of pneumococcal meningitis in adult patients, 0.15 mg/kg IV Q6H dexomethasone should be administered for 2 to 4 days. | | * In case of high suspicion of pneumococcal meningitis in adult patients, 0.15 mg/kg IV Q6H dexomethasone should be administered for 2 to 4 days. |
| ** The first dose of dexomethasone is given along with or 20 minutes prior to starting the antibiotics treatment. | | ** The first dose of dexomethasone is given along with or 20 minutes prior to starting the antibiotics treatment. |
|
| |
| {|
| |
| |-
| |
| | valign=top |
| |
| {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:20em" cellpadding="0" cellspacing="0";
| |
| ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Age <1 Week}}''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 50 mg/kg IV q8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 100—150 mg/kg/day IV q8—12h'''''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 50 mg/kg IV q8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2.5 mg/kg IV q12h'''''
| |
| |-
| |
|
| |
|
| |
| |}
| |
| | valign=top |
| |
| {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:20em" cellpadding="0" cellspacing="0";
| |
| ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Age 1—4 Weeks}}''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 150—200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2.5 mg/kg IV q8h''''' <BR> OR <BR> ▸ '''''[[Tobramycin]] 2.5 mg/kg IV q8h''''' <BR> OR <BR> ▸ '''''[[Amikacin]] 10 mg/kg IV q8h'''''
| |
| |-
| |
|
| |
|
| |
| |}
| |
| | valign=top |
| |
| {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:20em" cellpadding="0" cellspacing="0";
| |
| ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Age 1—23 Months}}''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 150—200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
|
| |
|
| |
| ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV q6—8h'''''
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND
| |
| |-
| |
| | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2.5 mg/kg IV q8h''''' <BR> OR <BR> ▸ '''''[[Tobramycin]] 2.5 mg/kg IV q8h''''' <BR> OR <BR> ▸ '''''[[Amikacin]] 10 mg/kg IV q8h'''''
| |
| |-
| |
|
| |
|
| |
| |}
| |
|
| |
|
| |
| <!--
| |
| ;Shown below is a table summarizing the preferred and alternative empiric treatment for meningitis.<ref name="pmid15494903">{{cite journal |author=Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ |title=Practice guidelines for the management of bacterial meningitis |journal=[[Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America]] |volume=39 |issue=9 |pages=1267–84 |year=2004 |month=November |pmid=15494903 |doi=10.1086/425368 |url=http://www.cid.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15494903 |accessdate=2012-11-28}}</ref>
| |
|
| |
| {| class="wikitable" border="1" style="background:FloralWhite"
| |
| |- align="center"
| |
| |'''Characteristics of the Patient'''
| |
| |'''Possible Pathogens'''
| |
| |'''Preferred Treatment'''
| |
| |'''Duration of Treatment'''
| |
| |'''Alternative Treatment'''
| |
| |- align="center"
| |
| |'''Immunocompentent patient'''
| |
|
| |
| '''Age<50'''
| |
| |Streptococcus pneumonia,
| |
|
| |
| Nisseria meningitis,
| |
|
| |
| Hemophilus influenzae
| |
| |'''Vancomycin'''
| |
|
| |
| Loading dose:25-35 mg/kg, then 15-20 mg/kg Q8-12H
| |
|
| |
| Trough concentration: 20mcg/mL
| |
|
| |
| '''+'''
| |
|
| |
| '''Ceftriaxone'''
| |
|
| |
| 2 g IV Q12H
| |
| |Stop or adjust treatment choice and duration when the results of the lumbar puncture are out
| |
| |In case of penicillin allergy:
| |
| Chloramphenicol
| |
|
| |
| '''+'''
| |
|
| |
| Vancomycin
| |
| |- align="center"
| |
| |'''Immunocompentent patient'''
| |
|
| |
| '''Age>50'''
| |
| |Streptococcus pneumonia,
| |
|
| |
| Listeria,
| |
|
| |
| Nisseria meningitis,
| |
|
| |
| Group B streptococci,
| |
|
| |
| Hemophilus influenzae
| |
| |'''Vancomycin'''
| |
|
| |
| Loading dose:25-35 mg/kg, then 15-20 mg/kg Q8-12H
| |
|
| |
| Trough concentration: 20mcg/mL
| |
|
| |
| '''+'''
| |
|
| |
| '''Ceftriaxone'''
| |
|
| |
| 2 g IV Q12H
| |
|
| |
| '''+'''
| |
|
| |
| '''Ampicillin'''
| |
|
| |
| 2 g IV Q4H
| |
| |Stop or adjust treatment choice and duration when the results of the lumbar puncture are out
| |
| |In case of penicillin allergy:
| |
| Chloramphenicol
| |
|
| |
| '''+'''
| |
|
| |
| Vancomycin
| |
|
| |
| '''+'''
| |
|
| |
| TMP/SMX
| |
| |- align="center"
| |
| |'''Immunocompromised patient'''
| |
| |Streptococcus pneumonia,
| |
|
| |
| Nisseria meningitis,
| |
|
| |
| Hemophilus influenzae,
| |
|
| |
| Listeria,
| |
|
| |
| (Gram-negatives)
| |
| |'''Vancomycin'''
| |
|
| |
| Loading dose:25-35 mg/kg, then 15-20 mg/kg Q8-12H
| |
|
| |
| Trough concentration: 20mcg/mL
| |
|
| |
| '''+'''
| |
|
| |
| '''Cefepime'''
| |
|
| |
| 2 g IV Q8H
| |
|
| |
| '''+'''
| |
|
| |
| '''Ampicillin'''
| |
|
| |
| 2 g IV Q4H
| |
| |Stop or adjust treatment choice and duration when the results of the lumbar puncture are out
| |
| |In case of penicillin allergy:
| |
| Vancomycin
| |
|
| |
| '''+'''
| |
|
| |
| TMP/SMX
| |
|
| |
| '''+'''
| |
|
| |
| Ciprofloxacin
| |
| |- align="center"
| |
| |'''Patient with history of penetrating head trauma or neurosurgery'''
| |
| |Streptococcus pneumonia (if CSF leak),
| |
|
| |
| Hemophilus influenzae,
| |
|
| |
| Staphylococci,
| |
|
| |
| (Gram-negatives)
| |
| |'''Vancomycin'''
| |
|
| |
| Loading dose:25-35 mg/kg, then 15-20 mg/kg Q8-12H
| |
|
| |
| Trough concentration: 20mcg/mL
| |
|
| |
| '''+'''
| |
|
| |
| '''Cefepime'''
| |
|
| |
| 2 g IV Q8H
| |
| |Stop or adjust treatment choice and duration when the results of the lumbar puncture are out
| |
| |In case of penicillin allergy:
| |
| Vancomycin
| |
|
| |
| '''+'''
| |
|
| |
| Ciprofloxacin
| |
| |- align="center"
| |
| |'''Shunt infection'''
| |
| |Streptococcus aureus,
| |
|
| |
| Coagulase negative staphylococci,
| |
|
| |
| Gram-negatives (rare)
| |
| |'''Vancomycin'''
| |
|
| |
| Loading dose:25-35 mg/kg, then 15-20 mg/kg Q8-12H
| |
|
| |
| Trough concentration: 20mcg/mL
| |
|
| |
| '''+'''
| |
|
| |
| '''Cefepime'''
| |
|
| |
| 2 g IV Q8H
| |
| |Stop or adjust treatment choice and duration when the results of the lumbar puncture are out
| |
| |In case of penicillin allergy:
| |
| Vancomycin
| |
|
| |
| '''+'''
| |
|
| |
| Ciprofloxacin
| |
| |}
| |
|
| |
| -->
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| [[Category:Needs overview]]
| |
| [[Category:Primary care]]
| |
| [[Category:Disease]]
| |
| [[Category:Infectious disease]]
| |
| [[Category:Neurology]]
| |
| [[Category:Emergency medicine]]
| |
| [[Category:Diseases involving the fasciae]]
| |
| [[Category:Inflammations]]
| |
| [[Category:Neurological disorders]]
| |
|
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
|
| |
|
| |
|
| |
|
| {| | | {| |